New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - docetaxel 140mg - concentrate for injection - 140 mg - active: docetaxel 140mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - docetaxel 140mg - concentrate for injection - 140 mg - active: docetaxel 140mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - evolocumab 140 mg/ml - 140 mg/ml

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - evolocumab 140 mg/ml - 140 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 140mg;   - capsule - 140 mg - active: temozolomide 140mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin indigo carmine lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - estramustine phosphate sodium eqv estramustine - capsule - 140 mg - estramustine phosphate sodium eqv estramustine 140 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ibrutinib 140mg;  ;   - capsule - 140 mg - active: ibrutinib 140mg     excipient: croscarmellose sodium gelatin magnesium stearate microcrystalline cellulose opacode black s-1-17822 opacode black s-1-17823 sodium laurilsulfate titanium dioxide - imbruvica is indicated for the treatment of · patients with mcl who have received at least one prior therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - selexipag, quantity: 1400 microgram - tablet, film coated - excipient ingredients: mannitol; maize starch; hyprolose; hypromellose; propylene glycol; magnesium stearate; titanium dioxide; carnauba wax; iron oxide yellow - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 140 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; purified water; stearic acid; indigo carmine; colloidal anhydrous silica; tartaric acid; gelatin; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,- patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment. - recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as a first-line treatment for patients with advanced metastatic malignant melanoma.